Carbidopa and Levodopa
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
60219-2033 -
Package NDC
60219-2033-1 -
Package NDC
60219-2033-3 -
Package NDC
60219-2033-5 -
Application number
ANDA076521 -
SPL ID
b5ad7e75-c6cd-4b2d-a3bf-e2e860d5b9c1 -
SPL set ID
0eb24333-3c11-41dd-888d-3a30d3c9d188 -
UNII
MNX7R8C5VO -
UNII
46627O600J -
RxCUI
308988 -
RxCUI
308989
What the source publishes
- Labeler
- Amneal Pharmaceuticals NY LLC
- Active ingredients
- CARBIDOPA and LEVODOPA
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Carbidopa and Levodopa",
"splId": "b5ad7e75-c6cd-4b2d-a3bf-e2e860d5b9c1",
"labels": [
{
"setId": "0eb24333-3c11-41dd-888d-3a30d3c9d188",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0eb24333-3c11-41dd-888d-3a30d3c9d188",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0eb24333-3c11-41dd-888d-3a30d3c9d188"
}
],
"routes": [
"ORAL"
],
"labeler": "Amneal Pharmaceuticals NY LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60219-2033-1)",
"package_ndc": "60219-2033-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20221221"
},
{
"sample": false,
"description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (60219-2033-3)",
"package_ndc": "60219-2033-3",
"identifierStatus": "well-formed",
"marketing_start_date": "20221221"
},
{
"sample": false,
"description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60219-2033-5)",
"package_ndc": "60219-2033-5",
"identifierStatus": "well-formed",
"marketing_start_date": "20221221"
}
],
"productId": "60219-2033_b5ad7e75-c6cd-4b2d-a3bf-e2e860d5b9c1",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "60219-2033",
"deaSchedule": null,
"genericName": "CARBIDOPA and LEVODOPA",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CARBIDOPA HYDRATE",
"strength": "25 mg/1"
},
{
"name": "LEVODOPA",
"strength": "100 mg/1"
}
],
"applicationNumber": "ANDA076521",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20221221",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000193220",
"M0370111"
],
"upc": [
"0360219203310",
"0360219203419"
],
"unii": [
"MNX7R8C5VO",
"46627O600J"
],
"rxcui": [
"308988",
"308989"
],
"spl_set_id": [
"0eb24333-3c11-41dd-888d-3a30d3c9d188"
],
"pharm_class_cs": [
"Amino Acids, Aromatic [CS]"
],
"pharm_class_epc": [
"Aromatic Amino Acid [EPC]"
],
"manufacturer_name": [
"Amneal Pharmaceuticals NY LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:60219-2033_b5ad7e75-c6cd-4b2d-a3bf-e2e860d5b9c1"